
Natera, Inc. (NTRA) earnings
- Healthcare
- NASDAQ
- Market cap$39.6B
Next report
2027-02-25
In 96 daysQ4 FY2026Time not announced· Expected date
- EPS consensus
- -0.16
- -4.48 – 1.887 analysts
- Revenue consensus
- $781M
Latest result
16 days ago-49.4%EPS Miss
2026-11-05Q3 FY2026AMC
- EPS
- Reported / estimate-0.42 / -0.28
- Revenue
- $794M / $708M+12.2%
Stock reaction
-14.59%
-14.91 pts vs SPY
Session 2026-11-06
Recent quarters
Latest 12 quartersRevenue and stock reaction
Beat in 4 of 8 quarters with a measured stock reaction · beat then fell 1 · average move (last 8) ±8.3%
| Quarter | EPSReported / estimate | RevenueReported / estimate | Reaction |
|---|---|---|---|
Q3 FY2026 2026-11-05 | -0.42 / -0.28 -49.4% | $794M / $708M +12.2% | -14.59% -14.91 pts vs SPY Session 2026-11-06 |
Q2 FY2026 2026-08-06 | -0.47 / -0.49 +4.8%¶ | $753M / $661M +13.8%¶ | +21.37% +20.76 pts vs SPY Session 2026-08-07 |
Q1 FY2026 2026-05-07 | -0.56 / -0.54 -3.3%¶ | $697M / $617M +12.9%¶ | -11.64% -12.46 pts vs SPY Session 2026-05-08 |
Q4 FY2025 2026-02-26 | 0.35 / -0.51 +168.3%†¶ | $666M / $604M +10.2%¶ | -3.73% -3.25 pts vs SPY Session 2026-02-27 |
Q3 FY2025 2025-11-06 | -0.64 / -0.39 -65.9%†¶ | $592M / $513M +15.3%¶ | +0.55% +0.45 pts vs SPY Session 2025-11-07 |
Q2 FY2025 2025-08-07 | -0.74 / -0.62 -20.2%¶ | $547M / $476M +14.8%¶ | +7.70% +6.93 pts vs SPY Session 2025-08-08 |
Q1 FY2025 2025-05-08 | -0.50 / -0.64 +21.9%¶ | $502M / $446M +12.5%¶ | -6.53% -6.41 pts vs SPY Session 2025-05-09 |
Q4 FY2024 2025-02-27 | -0.41 / -0.38 -7.6%¶ | $476M / $436M +9.3%¶ | -0.65% -2.21 pts vs SPY Session 2025-02-28 |
Q3 FY2024 2024-11-12 | -0.26 / -0.57 +54.4%†¶ | $440M / $361M +21.7%¶ | +19.13% +19.08 pts vs SPY Session 2024-11-13 |
Q2 FY2024 2024-08-08 | -0.30 / -0.69 +56.5%†¶ | $413M / $343M +20.5%¶ | +6.38% +5.94 pts vs SPY Session 2024-08-09 |
Q1 FY2024 2024-05-09 | -0.56 / -0.71 +21.1%¶ | $368M / $316M +16.3%¶ | +10.19% +10.06 pts vs SPY Session 2024-05-10 |
Q4 FY2023 2024-02-28 | -0.64 / -0.73 +12.3%¶ | $311M / $300M +3.7%¶ | +12.98% +12.63 pts vs SPY Session 2024-02-29 |
Reported / estimate
- Q3 FY2026 · 2026-11-05-14.59%EPS-0.42 / -0.28-49.4%Revenue$794M / $708M+12.2%
- Q2 FY2026 · 2026-08-06+21.37%EPS-0.47 / -0.49+4.8%¶Revenue$753M / $661M+13.8%¶
- Q1 FY2026 · 2026-05-07-11.64%EPS-0.56 / -0.54-3.3%¶Revenue$697M / $617M+12.9%¶
- Q4 FY2025 · 2026-02-26-3.73%EPS0.35 / -0.51+168.3%†¶Revenue$666M / $604M+10.2%¶
- Q3 FY2025 · 2025-11-06+0.55%EPS-0.64 / -0.39-65.9%†¶Revenue$592M / $513M+15.3%¶
- Q2 FY2025 · 2025-08-07+7.70%EPS-0.74 / -0.62-20.2%¶Revenue$547M / $476M+14.8%¶
- Q1 FY2025 · 2025-05-08-6.53%EPS-0.50 / -0.64+21.9%¶Revenue$502M / $446M+12.5%¶
- Q4 FY2024 · 2025-02-27-0.65%EPS-0.41 / -0.38-7.6%¶Revenue$476M / $436M+9.3%¶
- Q3 FY2024 · 2024-11-12+19.13%EPS-0.26 / -0.57+54.4%†¶Revenue$440M / $361M+21.7%¶
- Q2 FY2024 · 2024-08-08+6.38%EPS-0.30 / -0.69+56.5%†¶Revenue$413M / $343M+20.5%¶
- Q1 FY2024 · 2024-05-09+10.19%EPS-0.56 / -0.71+21.1%¶Revenue$368M / $316M+16.3%¶
- Q4 FY2023 · 2024-02-28+12.98%EPS-0.64 / -0.73+12.3%¶Revenue$311M / $300M+3.7%¶
- †Unusually large: likely a one-off gain or charge, so not comparable with consensus
- ¶Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.
Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.